These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane. Vickroy TW; Roeske WR; Yamamura HI J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869 [TBL] [Abstract][Full Text] [Related]
4. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes. Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580 [TBL] [Abstract][Full Text] [Related]
5. Agonist interactions with cardiac muscarinic receptors. Effects of Mg2+, guanine nucleotides, and monovalent cations. McMahon KK; Hosey MM Mol Pharmacol; 1985 Nov; 28(5):400-9. PubMed ID: 4058421 [TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor: regulation by guanine nucleotides, ions, and N-ethylmaleimide. Ehlert FJ; Roeske WR; Yamamura HI Fed Proc; 1981 Feb; 40(2):153-9. PubMed ID: 7461140 [TBL] [Abstract][Full Text] [Related]
7. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites. Cioffi CL; el-Fakahany EE J Pharmacol Exp Ther; 1986 Sep; 238(3):916-23. PubMed ID: 3018226 [TBL] [Abstract][Full Text] [Related]
8. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart. Martin MW; Smith MM; Harden TK J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149 [TBL] [Abstract][Full Text] [Related]
9. Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane. Galper JB; Haigh LS; Hart AC; O'Hara DS; Livingston DJ Mol Pharmacol; 1987 Aug; 32(1):230-40. PubMed ID: 3112557 [TBL] [Abstract][Full Text] [Related]
10. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations. Ladner CJ; Lee JM Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152 [TBL] [Abstract][Full Text] [Related]
11. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex. Ehlert FJ; Jenden DJ Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562 [TBL] [Abstract][Full Text] [Related]
12. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770 [TBL] [Abstract][Full Text] [Related]
13. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites. Waelbroeck M; Gillard M; Robberecht P; Christophe J Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520 [TBL] [Abstract][Full Text] [Related]
14. A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes. Watson M; Yamamura HI; Roeske WR Life Sci; 1983 Jun; 32(26):3001-11. PubMed ID: 6688111 [TBL] [Abstract][Full Text] [Related]
15. Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide. Ehlert FJ; Roeske WR; Yamamura HI J Supramol Struct; 1980; 14(2):149-62. PubMed ID: 7230804 [TBL] [Abstract][Full Text] [Related]
16. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites. Waelbroeck M; Robberecht P; Chatelain P; Christophe J Mol Pharmacol; 1982 May; 21(3):581-8. PubMed ID: 7110116 [TBL] [Abstract][Full Text] [Related]
17. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Flynn DD; Weinstein DA; Mash DC Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942 [TBL] [Abstract][Full Text] [Related]
18. Requirement for sulfhydryl groups in the differential effects of magnesium ion and GTP on agonist binding of muscarinic cholinergic receptor sites in rat atrial membrane fraction. Wei JW; Sulakhe PV Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):51-9. PubMed ID: 7442826 [TBL] [Abstract][Full Text] [Related]
19. Muscarinic receptors in the stomach. Hammer R Scand J Gastroenterol Suppl; 1980; 66():5-11. PubMed ID: 6941378 [TBL] [Abstract][Full Text] [Related]
20. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. Luthin GR; Wolfe BB Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]